New York, NY -- (SBWIRE) -- 09/16/2013 -- StockMarketIntel.com issues a special report on the following stocks: OncoSec Medical Inc (OTCMKTS:ONCS), A.P. Pharma, Inc. (OTCBB:APPA), Chromadex Corp (OTCMKTS:CDXC), Kirin Holdings Company, Limited. (ADR) (OTCMKTS:KNBWY)
OncoSec Medical Inc (OTCMKTS:ONCS) gained 8.11%, trading on 1.47 million shares, to end the trade at $0.320. If we look at its trading history of the past 52 weeks, the share price suffered a low of $0.18 and was moved to the maximum level of $0.49. The stock changed hands in a range of $0.28 to $0.30, bringing its market capitalization to about $28.29 million. OncoSec Medical Incorporated designs, develops, and commercializes novel cancer therapeutic products in the United States. Its products combine proprietary electroporation delivery technology with a chemotherapeutic or novel DNA-based immunotherapeutics, known as OMS ElectroOncology.
Will ONCS Continue To Move Higher? Find Out Here
A.P. Pharma, Inc. (OTCBB:APPA) declined -0.56% complete the trading session at $0.358, with a total volume of 1.47 million shares. The stock, on average, trades on a volume of 650,663 shares. In the past 52 weeks, the share price has not declined below $0.28 and above $0.89. It floated in a range of $0.35 to $038 during the last trading session, with a beta value of 0.62. Its market capitalization now moved to about $109.89 million. A.P. Pharma, Inc., a specialty pharmaceutical company, engages in developing pharmaceutical products using its proprietary Biochronomer polymer-based drug delivery technology. Its Biochronomer technology consists of bioerodible polymers designed to release drugs over a defined period of time; and is applicable to a range of therapeutic areas, including pain management, prevention of nausea, control of inflammation, and treatment of ophthalmic diseases.
Why Should Investors Buy APPA After the Recent Fall? Just Go Here and Find Out
Chromadex Corp (OTCMKTS:CDXC) declined -0.17%, to complete the trading session at $0.830, with a total volume of 85,000 shares. The stock, on average, trades on a volume of 197,064 shares. It floated in a range of $0.81 to $0.85 during the last trading session, with a beta value of 1.40. Its market capitalization now moved to about $84.08 million. In the past 52 weeks, the share price has not declined below $0.50 and above $1.25. ChromaDex Corporation, a natural products company, through its subsidiaries, discovers, acquires, develops, and commercializes proprietary-based ingredient technologies. The company utilizes its wholly-owned synergistic business units, including ingredient technologies, natural product fine chemicals, chemistry and analytical testing services, and product regulatory and safety consulting. It provides seamless science-based solutions to the dietary supplement, food and beverage, animal health, cosmetic, and pharmaceutical industries.
Has CDXC Found The Bottom and Ready To Move Up? Find Out Here
Kirin Holdings Company, Limited. (ADR) (OTCMKTS:KNBWY) added 1.52%, bringing its market capitalization around $13.27 billion. The share price, after opening at $14.04, made a high of $14.04 and hovered above $13.96 to end the day at $14.04. The total number of shares that changed hands during the session was 41,098 shares, as compared to average trading volume of 47,467 shares. Kirin Holdings Company, Limited engages in the manufacture and sale of alcoholic and non-alcoholic beverages, and pharmaceuticals and bio-chemical products in Japan, Oceania, Brazil, Southeast Asia, and other regions. It operates in four segments: Domestic Alcohol Beverages, Domestic Non-alcohol Beverages, Overseas Beverages, and Pharmaceuticals and Bio-chemicals.
Why Should Investors Buy KNBWY After The Recent Gain? Just Go Here and Find Out
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)